Prot# NB19751A: A Double-Blind, Placebo-Controlledd Efficacy(as Assessed by Post-Bronchodilator FEV1) & Safety Study of 5mg R03300074 Once-Daily for 2 Years in Subjects with Smoking-Related, Moderate-to Severe COPD with Emphysema Receiving Optimal COPD Dr

Project: Research project

Project Details

StatusFinished
Effective start/end date3/29/07 → 3/29/10

Funding

  • Quintiles, Inc. (NB19751A/NB19751RG)
  • Hoffman-La Roche, Inc. (NB19751A/NB19751RG)